Home > Products > CD64 & HER2
> Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scFv-Fc-scFv)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scFv-Fc-scFv) (CAT#: BSTF-128)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scFv-Fc-scFv) is designed to be expressed as one chain, then assembled to a homodimer of bivalent scFv fragments and the Fc region of IgG. The anti-CD64 scFv is fused to the N-terminus of Fc via a hinge region while another anti-HER2 scFv is linked to the C-terminus of Fc. This scFv-Fc-scFv format has 2+2 antigen-binding valency by employing different scFv fragments. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scFv-Fc-scFv) (BSTF-128). Click the button below to contact us or submit your feedback about this product.